The announcement of the US federal budget for fiscal year 2008 (October 1, 2007–September 30, 2008) was grim news for science R&D supporters. According to a preliminary analysis by the American Association for the Advancement of Science (AAAS), the total US federal R&D budget increased only 1.2% for fiscal 2008 to $142,715 million. This amount […]
This month, the National Institutes of Health (NIH) announced the Human Microbiome Project. The human microbiome is comprised of the genomes of every micro-organism in humans. The Project will provide $115 million over five years to sequence and characterize at least 600 microbial genomes. Samples will be grown in laboratories and collected from the digestive […]
According to government estimates, 2007 Canadian R&D spending reached almost CAD 29.0 billion ($27.1 billion), a 3.3% increase over 2006’s CAD 28.1 billion ($24.8 billion). Academia accounted for 50.0%, or CAD 459 million ($428.2 million) of the increase, and industry accounted for 45.4%, or CAD 416 million ($388.1 million). Industry was the largest performer of […]
Microliter spectrophotometry is a technique used to measure extremely small sample sizes, but its market potential is anything but small. Recent activity in the market has reflected both large and small companies’ recognition of the prospects of microliter spectrophotometry. In October, Thermo Fisher Scientific acquired NanoDrop (see IBO 10/15/07), the market leader. Next year, GE […]
An article in the November 15, 2007, issue of IBO discussed increased concerns about food imports, particularly from China. On December 11, the US and China announced a formal agreement to improve food safety. The agreement applies to four products categories: “low-acid canned products or acidified food”; “pet food/pet treats of plant origin or animal […]
The boom in the metals market have led to record prices and a steep increase in profits for mining companies. Satisfying the current demand for the minerals to make metals requires new exploration, as well as faster and more efficient mining and processing. Such needs have stimulated demand for automated analysis techniques that provide higher […]
Firms that produce monoclonal antibodies (mAbs) have proven to be a popular acquisition choice for pharmaceutical companies. Some of the larger acquisitions of mAb producers by pharmaceutical companies this year were Bristol-Myers Squibb’s purchase of Adnexus for $415 million in September and Roche’s $56.5 million payout for Therapeutic Human Polyclonals in April. This trend can […]
A worldwide shortage of helium is driving prices of the element higher, forcing helium users in many industries to adapt. Demand for helium has been boosted by a wide array of scientific uses, increasing by 80% over the last 20 years in the US and rising by more than 20% annually in developing economies. Because […]
Witnesses at last month’s hearing of the House Energy and Commerce Subcommittee on Oversight and Investigations detailed the FDA’s insufficient policies for assuring the quality of foreign-manufactured drugs and active pharmaceutical ingredients (APIs). According to the GAO, 80% of APIs and 40% of all finished drugs sold in the US are imported. The GAO said […]
According to the latest figures released by the National Science Foundation (NSF), spending on science and engineering (S&E) R&D at US universities and colleges rose 4.3% in fiscal 2006 (ended September 30, 2006) to $47,476 million. As the pie chart below illustrates, spending by the federal government made up the lion’s share of academic R&D […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
